Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection. - Wikidata - wikimedia - TriplyDB

Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.

Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.

http://www.wikidata.org/entity/Q37123259

about

Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host Development, characterization and application of monoclonal antibodies against Brazilian Dengue virus isolates Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies.Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein Temperature dependent conformational change of dengue virus Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III.A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing.Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model.A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.B cell response and mechanisms of antibody protection to West Nile virus.DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics.HCV E2 core structures and mAbs: something is still missing.Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development.A mouse monoclonal antibody against dengue virus type 1 Mochizuki strain targeting envelope protein domain II and displaying strongly neutralizing but not enhancing activity.Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials.Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies.Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection.A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo.Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice.

P2860

Q23925011-598C9464-D45F-490A-91E6-86D6ABB70731 Q24288673-B31358B6-23E6-4F97-AC19-1DCABD46C954 Q26314715-FB366E56-71F6-42CF-AA11-24F489A7DF1E Q26700120-6D3E69A2-E0CE-4368-840B-2B01F31452EA Q26860116-C480C614-45AD-4242-8695-415285292BA6 Q27304342-59001780-C66B-45AC-9D91-BD584D2B8181 Q27654848-47C94F8B-380F-421D-8D6C-19B1B6252C23 Q28114614-0DF68D96-7FE0-4421-8B6E-3BA92C88C20C Q30145645-B40178B6-70DB-49FB-93B9-612F6492F25C Q30395028-A3600380-DE8E-4CBB-8765-D0C0C64E55A1 Q33422520-A2A737B4-2D07-4153-B473-C26C6616BA8B Q33425879-342B18CD-58F9-42F1-81D2-122126147DEF Q34262245-41DE5063-6F6E-49D7-BF02-A1E52F9131C1 Q34386384-7BF9D607-B550-413C-86B1-B114CBADCCC8 Q35751849-0150DA12-B68A-44DE-AE3B-EFB5CCD1077C Q35796610-34355E09-9086-401F-813D-E3D3E11527BB Q36205859-36C8E6C1-4F6A-4340-BC62-CACDEDDB53FA Q36245225-738C4037-8938-47DF-B98B-F9093D5CFADE Q36255068-F0DD3A2C-CAE1-4B33-9B3A-188FF61A2714 Q37012203-3DB84919-D493-4B51-8A02-7FA81D5DF102 Q37673123-A96E32AF-FFE4-445D-9F58-F3C06A0D1546 Q38157397-83F82B1F-7021-47EA-8A63-8E5F87E3F6CD Q38161994-2E136332-867A-47E1-A7B9-2D200E94D03E Q38244787-C558C2F5-EC78-43B3-BEBD-6E13F5D5DCF7 Q38636217-8B149206-9B76-4F1C-9EAA-24EDAB760A69 Q39535403-31552A25-9E48-4105-ACB6-0C03CAE16723 Q39611340-DE44EABB-2571-4068-9EC5-7B9C3C99C6A0 Q40047887-8EF76773-EA24-494E-A7E0-BE2C8178DA91 Q40136145-C710C696-8BF6-4904-9A0C-CD16BBCB99BF Q41929032-E4C1CB1F-4609-43A1-9063-E57260922771 Q47194469-0C096EA1-489A-4632-951B-37D5E321C0BC Q47549097-5A4E59E7-AC42-45EC-B9DC-7F59D3520789 Q47562022-BE697537-C520-4F66-90A9-079937CC09BA Q55244392-13B48900-1443-4946-AA4F-AB8A4D76CEE1

P2860

Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.

http://www.wikidata.org/entity/Q37123259

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Functional analysis of antibod ...... neutralization and protection.

@en

Functional analysis of antibod ...... neutralization and protection.

@nl

type

label

Functional analysis of antibod ...... neutralization and protection.

@en

Functional analysis of antibod ...... neutralization and protection.

@nl

prefLabel

Functional analysis of antibod ...... neutralization and protection.

@en

Functional analysis of antibod ...... neutralization and protection.

@nl

P1433

Q37123259-F18C73B0-AAF6-4FBA-98D1-2BA8A006BBE9

P1476

Q37123259-8D902B9D-A1BA-4405-9AA1-00666CB243AA

P2093

Q37123259-03172A1D-58A8-4BE4-AF51-C36897B7FC67

Q37123259-287D36BC-7DB4-4449-B71B-1DDE371C4B78

Q37123259-306DF1AD-7E90-4587-8BDD-F223C545D3BC

Q37123259-68C9665E-D15B-4A23-ADCE-033B7081EF56

Q37123259-6C99012A-E2CE-46E9-B345-A39BFB8D9E08

Q37123259-C23CBB5C-1FE0-4CF8-B005-C970D6B3F48F

Q37123259-FD0B5B6B-A86D-4DC1-BC5F-18FC3D3FE5C5

P2860

Q37123259-03A1658B-D599-42A3-BF80-E36FEB758DE9

Q37123259-062DC595-5680-4935-92F3-E22D09EE97BC

Q37123259-0E56EDEF-205A-4625-8E98-B5B2836C77EB

Q37123259-0F1E7071-34EB-4F1E-BA6C-860B0A69526D

Q37123259-1261E816-C8B4-4045-B013-8CE9736CA0FA

Q37123259-176C761B-6453-494B-8DE3-379FBB106045

Q37123259-18907B04-4250-47E8-BF61-48B5122DB0F6

Q37123259-192B6DD0-814F-40F7-8DA5-A5081C0ABAE9

Q37123259-1B73FC8C-749E-470A-BE6B-0F68A8C3C580

Q37123259-1D046EB6-3E7D-4E16-AA79-594870F85B85

P304

Q37123259-58DCEE37-EEF9-4BBC-9B6D-88355AB8E619

P31

Q37123259-BBC1D26D-2FE0-4E2E-A10E-AD8C16D169A1

P356

Q37123259-A4389AF4-33D6-4212-AD9A-EA91879D0A86

P407

Q37123259-C6DFD8BB-2B11-4936-9B34-9164C998EB17

P433

Q37123259-ECF8711E-99D1-45B7-A9A5-DE66321EC669

P478

Q37123259-5AE44E4B-5C3B-4A80-B411-5AB64817161A

P50

Q37123259-5C2BC540-222B-42BE-B5F2-2D362035F84C

Q37123259-91A7CC46-E507-4215-B4D8-9870091E3975

Q37123259-A98923F6-1005-49E8-B10B-1A4A7CEAE4F2

Q37123259-F1B04111-8487-4427-AC21-F202003AED04

P577

Q37123259-27585158-882A-49E7-8214-52B56041E5DA

P698

Q37123259-42E46422-80A9-4669-A580-E552E183675F

P921

Q37123259-9A70B8F3-6802-4527-BF8F-CEF9344657EF

Q37123259-F6F8AC22-0A6C-40A0-BCBE-90A2B69051F9

P932

Q37123259-EF570BDC-EE4C-48FC-8CB2-C89BF365C76B

P356

P1433

Journal of Virology

P1476

Functional analysis of antibod ...... neutralization and protection.

@en

P2093

Benjamin J Doranz

http://www.w3.org/2001/XMLSchema#string

Daved H Fremont

http://www.w3.org/2001/XMLSchema#string

James D Brien

http://www.w3.org/2001/XMLSchema#string

Kristen Kahle

http://www.w3.org/2001/XMLSchema#string

S Kyle Austin

http://www.w3.org/2001/XMLSchema#string

Sherri Swayne

http://www.w3.org/2001/XMLSchema#string

Syd Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

DENV inhibits type I IFN production in infected cells by cleaving human STING

Dengue virus targets the adaptor protein MITA to subvert host innate immunity

Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses

Atomic-level mapping of antibody epitopes on a GPCR

Dengue: defining protective versus pathologic immunity

The global distribution and burden of dengue

NS5 of dengue virus mediates STAT2 binding and degradation

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

P304

8826-8842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01314-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Diamond

Soila Sukupolvi-Petty

Theodore C Pierson

P577

2013-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23785205

http://www.w3.org/2001/XMLSchema#string

P921

P932

3754038

http://www.w3.org/2001/XMLSchema#string